177 related articles for article (PubMed ID: 7515117)
1. [Anti-thyrotropin (TSH) receptor antibody binding epitopes of TSH receptor: site-directed mutagenesis approach].
Akamizu T; Kosugi S; Kohn LD; Mori T
Nihon Rinsho; 1994 Apr; 52(4):1024-30. PubMed ID: 7515117
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of epitopes for TSH receptor autoantibodies using TSH receptor/LH-CG receptor chimeras].
Tahara K; Yamamoto K; Tamura Y; Yoshida S
Nihon Rinsho; 1994 Apr; 52(4):1031-6. PubMed ID: 7515118
[TBL] [Abstract][Full Text] [Related]
3. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
Kosugi S; Ban T; Akamizu T; Kohn LD
Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
[TBL] [Abstract][Full Text] [Related]
4. The extracellular domain of the TSH receptor has an immunogenic epitope reactive with Graves' IgG but unrelated to receptor function as well as determinants having different roles for high affinity TSH binding and the activity of thyroid-stimulating autoantibodies.
Kosugi S; Akamizu T; Takai O; Prabhakar BS; Kohn LD
Thyroid; 1991; 1(4):321-30. PubMed ID: 1726785
[TBL] [Abstract][Full Text] [Related]
5. Identification of thyroid-stimulating antibody-specific interaction sites in the N-terminal region of the thyrotropin receptor.
Kosugi S; Ban T; Kohn LD
Mol Endocrinol; 1993 Jan; 7(1):114-30. PubMed ID: 8095322
[TBL] [Abstract][Full Text] [Related]
6. Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TSHRAbs) derived from lymphocytes of patients with Graves' disease: epitope and binding study of two stimulatory TSHRAbs.
Akamizu T; Moriyama K; Miura M; Saijo M; Matsuda F; Nakao K
Endocrinology; 1999 Apr; 140(4):1594-601. PubMed ID: 10098493
[TBL] [Abstract][Full Text] [Related]
7. Further characterization of a high affinity thyrotropin binding site on the rat thyrotropin receptor which is an epitope for blocking antibodies from idiopathic myxedema patients but not thyroid stimulating antibodies from Graves' patients.
Kosugi S; Ban T; Akamizu T; Kohn LD
Biochem Biophys Res Commun; 1991 Oct; 180(2):1118-24. PubMed ID: 1719963
[TBL] [Abstract][Full Text] [Related]
8. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
[TBL] [Abstract][Full Text] [Related]
9. Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy.
Kung AW; Lau KS; Kohn LD
J Clin Endocrinol Metab; 2001 Aug; 86(8):3647-53. PubMed ID: 11502791
[TBL] [Abstract][Full Text] [Related]
10. [Topics on immunogenic regions in TSH receptors for thyroid disease].
Murakami M; Mori M
Rinsho Byori; 1993 Feb; 41(2):128-35. PubMed ID: 7689665
[TBL] [Abstract][Full Text] [Related]
11. Detection of functionally different types of pathological autoantibodies against thyrotropin receptor in Graves' patients sera by luminescent immunoprecipitation analysis.
Minich WB; Loos U
Exp Clin Endocrinol Diabetes; 2000; 108(2):110-9. PubMed ID: 10826518
[TBL] [Abstract][Full Text] [Related]
12. [Thyroid stimulating activity of human TSH-R peptide antibody].
Endo T; Onaya T
Nihon Rinsho; 1994 Apr; 52(4):1043-7. PubMed ID: 7515120
[TBL] [Abstract][Full Text] [Related]
13. Epitopes for thyroid stimulating and blocking autoantibodies on the extracellular domain of the human thyrotropin receptor.
Tahara K; Ishikawa N; Yamamoto K; Hirai A; Ito K; Tamura Y; Yoshida S; Saito Y; Kohn LD
Thyroid; 1997 Dec; 7(6):867-77. PubMed ID: 9459630
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis for the autoreactivity against thyroid stimulating hormone receptor.
Kohn LD; Kosugi S; Ban T; Saji M; Ikuyama S; Giuliani C; Hidaka A; Shimura H; Akamizu T; Tahara K
Int Rev Immunol; 1992; 9(2):135-65. PubMed ID: 1283175
[TBL] [Abstract][Full Text] [Related]
15. [On the localization of the binding site(s) of antibodies against TSH receptor using synthetic peptides].
Sakata S; Matsui K; Sarui H; Takuno H; Yasuda K
Nihon Rinsho; 1994 Apr; 52(4):1037-42. PubMed ID: 7515119
[TBL] [Abstract][Full Text] [Related]
16. Thyrotropin receptor autoantibodies (TSHRAbs): epitopes, origins and clinical significance.
Kohn LD; Harii N
Autoimmunity; 2003; 36(6-7):331-7. PubMed ID: 14669940
[TBL] [Abstract][Full Text] [Related]
17. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay.
Morgenthaler NG; Hodak K; Seissler J; Steinbrenner H; Pampel I; Gupta M; McGregor AM; Scherbaum WA; Banga JP
Thyroid; 1999 May; 9(5):466-75. PubMed ID: 10365678
[TBL] [Abstract][Full Text] [Related]
18. Use of thyrotropin receptor (TSHR) mutants to detect stimulating TSHR antibodies in hypothyroid patients with idiopathic myxedema, who have blocking TSHR antibodies.
Kosugi S; Ban T; Akamizu T; Valente W; Kohn LD
J Clin Endocrinol Metab; 1993 Jul; 77(1):19-24. PubMed ID: 8100829
[TBL] [Abstract][Full Text] [Related]
19. Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotrophin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay.
Baker JR; Lukes YG; Smallridge RC; Berger M; Burman KD
J Clin Invest; 1983 Oct; 72(4):1487-97. PubMed ID: 6138364
[TBL] [Abstract][Full Text] [Related]
20. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
Heyma P; Harrison LC
J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
